PHILADELPHIA, November 18, 2010 /PRNewswire/ -- Elsevier (http://www.elsevier.com/wps/find/homepage.cws_home), the leading publisher of scientific, technical and medical information products and services, today announced that the new HESI QuizMe app series for nursing students is available from the Apple App Store. These apps familiarize nursing students with clinically based scenarios, health problems and case studies commonly encountered in the nursing profession.
"Mobile technology provides an effective new training channel for health care students, and we are pleased to expand Elsevier's portfolio of apps with the HESI QuizMe series," said Ainslie Nibert, PhD, RN, vice-president, HESI Review & Testing. "Every time a user engages with the HESI QuizMe series, for a five minute session or for an hour, it's an opportunity to get better acquainted with the core nursing concepts that will carry these students through their careers."
The series addresses four key areas of nursing practice: maternity, medical-surgical, pediatrics, and psychiatric. Multiple apps within each specialty area drill down on core concepts to deliver focused review and skill building. Four HESI QuizMe medical-surgical apps are now available: Cardiovascular & Respiratory; Gastrointestinal & Genitourinary; Musculoskeletal, Neurological, & Eye/Ear; and Hepatic, Hemo & Endo. Additional apps in the series are forthcoming.
Each HESI QuizMe application provides a robust, customizable quizzing and assessment experience that includes:
- A multiple choice question library - Statistics highlighting quiz performance - Question browser for un-scored practice and review of questions - Optional question timer to help establish pace - Bookmarking to save questions for further review
The HESI QuizMe app series by Elsevier is designed specifically for iPhone and iPod touch, in partnership with Modality, a premier developer of medical reference and learning apps for iPad, iPhone and iPod touch.
These apps are available for $4.99 each from the App Store at http://www.itunes.com/appstore/
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell 9http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/home.url), Reaxys ( http://notice.reaxys.com/maintenance.html), MD Consult ( http://www.mdconsult.com/php/222075573-2/homepage) and Nursing Consult (http://www.nursingconsult.com/php/222075595-2/home.html), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC ( http://www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact Tom Reller Vice President of Global Relations, Elsevier +1-212-462-1912 T.Reller@Elsevier.com
SOURCE: Elsevier
CONTACT: Media Contact, Tom Reller, Vice President of Global Relations,Elsevier, +1-212-462-1912, T.Reller@Elsevier.com
Comments